MD Annual Cash & Cash Equivalents
$73.26 M
+$63.43 M+645.70%
31 December 2023
Summary:
As of January 22, 2025, MD annual cash & cash equivalents is $73.26 million, with the most recent change of +$63.43 million (+645.70%) on December 31, 2023. During the last 3 years, it has fallen by -$1.05 billion (-93.48%). MD annual cash & cash equivalents is now -93.48% below its all-time high of $1.12 billion, reached on December 31, 2020.MD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MD Quarterly Cash And Cash Equivalents
$103.83 M
+$84.43 M+435.16%
30 September 2024
Summary:
As of January 22, 2025, MD quarterly cash and cash equivalents is $103.83 million, with the most recent change of +$84.43 million (+435.16%) on September 30, 2024. Over the past year, it has increased by +$82.65 million (+390.25%). MD quarterly cash and cash equivalents is now -90.76% below its all-time high of $1.12 billion, reached on December 31, 2020.MD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MD Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +645.7% | +390.3% |
| 3 y3 years | -93.5% | +390.3% |
| 5 y5 years | +187.4% | +390.3% |
MD Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.1% | +645.7% | -73.2% | +1675.2% |
| 5 y | 5-year | -93.5% | +645.7% | -90.8% | +1675.2% |
| alltime | all time | -93.5% | >+9999.0% | -90.8% | >+9999.0% |
Pediatrix Medical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $103.83 M(+435.2%) |
| June 2024 | - | $19.40 M(+142.6%) |
| Mar 2024 | - | $8.00 M(-89.1%) |
| Dec 2023 | $73.26 M(+645.7%) | $73.26 M(+245.9%) |
| Sept 2023 | - | $21.18 M(+262.1%) |
| June 2023 | - | $5.85 M(-4.5%) |
| Mar 2023 | - | $6.12 M(-37.7%) |
| Dec 2022 | $9.82 M(-97.5%) | $9.82 M(+13.3%) |
| Sept 2022 | - | $8.67 M(-38.5%) |
| June 2022 | - | $14.09 M(+96.2%) |
| Mar 2022 | - | $7.18 M(-98.1%) |
| Dec 2021 | $387.39 M(-65.5%) | $387.39 M(+8.2%) |
| Sept 2021 | - | $357.91 M(+5.8%) |
| June 2021 | - | $338.16 M(+25.4%) |
| Mar 2021 | - | $269.63 M(-76.0%) |
| Dec 2020 | $1.12 B(+941.8%) | $1.12 B(+281.6%) |
| Sept 2020 | - | $294.51 M(+122.9%) |
| June 2020 | - | $132.15 M(-57.7%) |
| Mar 2020 | - | $312.15 M(+189.4%) |
| Dec 2019 | $107.87 M(+323.2%) | $107.87 M(+273.4%) |
| Sept 2019 | - | $28.89 M(+18.0%) |
| June 2019 | - | $24.48 M(-7.5%) |
| Mar 2019 | - | $26.48 M(+3.9%) |
| Dec 2018 | $25.49 M(-57.7%) | $25.49 M(-26.0%) |
| Sept 2018 | - | $34.46 M(-9.4%) |
| June 2018 | - | $38.06 M(-7.0%) |
| Mar 2018 | - | $40.94 M(-32.0%) |
| Dec 2017 | $60.20 M(+8.1%) | $60.20 M(+24.4%) |
| Sept 2017 | - | $48.40 M(+19.7%) |
| June 2017 | - | $40.42 M(-3.4%) |
| Mar 2017 | - | $41.84 M(-24.9%) |
| Dec 2016 | $55.70 M(+8.0%) | $55.70 M(+5.5%) |
| Sept 2016 | - | $52.80 M(+1.8%) |
| June 2016 | - | $51.89 M(-6.5%) |
| Mar 2016 | - | $55.49 M(+7.6%) |
| Dec 2015 | $51.57 M(+7.6%) | $51.57 M(-15.3%) |
| Sept 2015 | - | $60.91 M(-6.7%) |
| June 2015 | - | $65.32 M(+30.1%) |
| Mar 2015 | - | $50.22 M(+4.8%) |
| Dec 2014 | $47.93 M(+53.9%) | $47.93 M(-33.3%) |
| Sept 2014 | - | $71.82 M(+305.5%) |
| June 2014 | - | $17.71 M(-10.4%) |
| Mar 2014 | - | $19.77 M(-36.5%) |
| Dec 2013 | $31.14 M(+46.3%) | $31.14 M(+91.7%) |
| Sept 2013 | - | $16.24 M(+23.4%) |
| June 2013 | - | $13.16 M(-61.8%) |
| Mar 2013 | - | $34.42 M(+61.8%) |
| Dec 2012 | $21.28 M(+14.4%) | $21.28 M(-67.8%) |
| Sept 2012 | - | $66.12 M(+444.4%) |
| June 2012 | - | $12.15 M(-45.7%) |
| Mar 2012 | - | $22.39 M(+20.4%) |
| Dec 2011 | $18.60 M(-29.2%) | $18.60 M(-48.0%) |
| Sept 2011 | - | $35.75 M(+49.2%) |
| June 2011 | - | $23.96 M(+59.2%) |
| Mar 2011 | - | $15.05 M(-42.7%) |
| Dec 2010 | $26.25 M(-1.0%) | $26.25 M(-57.2%) |
| Sept 2010 | - | $61.39 M(+134.8%) |
| June 2010 | - | $26.14 M(+9.2%) |
| Mar 2010 | - | $23.94 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $26.50 M(+84.7%) | $26.50 M(+27.0%) |
| Sept 2009 | - | $20.86 M(+12.2%) |
| June 2009 | - | $18.60 M(-12.9%) |
| Mar 2009 | - | $21.34 M(+48.8%) |
| Dec 2008 | $14.35 M(-86.1%) | $14.35 M(+18.2%) |
| Sept 2008 | - | $12.14 M(-14.7%) |
| June 2008 | - | $14.23 M(-64.0%) |
| Mar 2008 | - | $39.49 M(-61.6%) |
| Dec 2007 | $102.84 M(+47.8%) | $102.84 M(+103.6%) |
| Sept 2007 | - | $50.51 M(-63.0%) |
| June 2007 | - | $136.61 M(+90.7%) |
| Mar 2007 | - | $71.63 M(+2.9%) |
| Dec 2006 | $69.59 M(+521.8%) | $69.59 M(+11.4%) |
| Sept 2006 | - | $62.50 M(+116.7%) |
| June 2006 | - | $28.84 M(+540.0%) |
| Mar 2006 | - | $4.51 M(-59.7%) |
| Dec 2005 | $11.19 M(+59.6%) | $11.19 M(+134.2%) |
| Sept 2005 | - | $4.78 M(-14.9%) |
| June 2005 | - | $5.61 M(+37.6%) |
| Mar 2005 | - | $4.08 M(-41.8%) |
| Dec 2004 | $7.01 M(-74.9%) | $7.01 M(-77.3%) |
| Sept 2004 | - | $30.91 M(+56.7%) |
| June 2004 | - | $19.72 M(-18.9%) |
| Mar 2004 | - | $24.31 M(-12.8%) |
| Dec 2003 | $27.90 M(-61.9%) | $27.90 M(+168.0%) |
| Sept 2003 | - | $10.41 M(-9.9%) |
| June 2003 | - | $11.55 M(-15.2%) |
| Mar 2003 | - | $13.63 M(-81.4%) |
| Dec 2002 | $73.19 M(+165.6%) | $73.19 M(+76.8%) |
| Sept 2002 | - | $41.40 M(-36.0%) |
| June 2002 | - | $64.73 M(+76.9%) |
| Mar 2002 | - | $36.60 M(+32.8%) |
| Dec 2001 | $27.56 M(+796.2%) | $27.56 M(+679.3%) |
| Sept 2001 | - | $3.54 M(-20.4%) |
| June 2001 | - | $4.44 M(+152.8%) |
| Mar 2001 | - | $1.76 M(-42.9%) |
| Dec 2000 | $3.08 M(+272.7%) | $3.08 M(+62.1%) |
| Sept 2000 | - | $1.90 M(+58.5%) |
| June 2000 | - | $1.20 M(+11.0%) |
| Mar 2000 | - | $1.08 M(+30.7%) |
| Dec 1999 | $825.00 K(+17.9%) | $825.00 K(+106.3%) |
| Sept 1999 | - | $400.00 K(-33.3%) |
| June 1999 | - | $600.00 K(0.0%) |
| Mar 1999 | - | $600.00 K(-14.3%) |
| Dec 1998 | $700.00 K(-96.2%) | $700.00 K(+16.7%) |
| Sept 1998 | - | $600.00 K(-66.7%) |
| June 1998 | - | $1.80 M(-37.9%) |
| Mar 1998 | - | $2.90 M(-84.4%) |
| Dec 1997 | $18.60 M(+1.1%) | $18.60 M(+64.6%) |
| Sept 1997 | - | $11.30 M(-58.8%) |
| June 1997 | - | $27.40 M(+22.9%) |
| Mar 1997 | - | $22.30 M(+21.2%) |
| Dec 1996 | $18.40 M(-0.5%) | $18.40 M(-51.6%) |
| Sept 1996 | - | $38.00 M(+276.2%) |
| June 1996 | - | $10.10 M(+42.3%) |
| Mar 1996 | - | $7.10 M(-61.6%) |
| Dec 1995 | $18.50 M(+150.0%) | $18.50 M(-58.3%) |
| Sept 1995 | - | $44.40 M(+500.0%) |
| Dec 1994 | $7.40 M | $7.40 M |
FAQ
- What is Pediatrix Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pediatrix Medical?
- What is Pediatrix Medical annual cash & cash equivalents year-on-year change?
- What is Pediatrix Medical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Pediatrix Medical?
- What is Pediatrix Medical quarterly cash and cash equivalents year-on-year change?
What is Pediatrix Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of MD is $73.26 M
What is the all time high annual cash & cash equivalents for Pediatrix Medical?
Pediatrix Medical all-time high annual cash & cash equivalents is $1.12 B
What is Pediatrix Medical annual cash & cash equivalents year-on-year change?
Over the past year, MD annual cash & cash equivalents has changed by +$63.43 M (+645.70%)
What is Pediatrix Medical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MD is $103.83 M
What is the all time high quarterly cash and cash equivalents for Pediatrix Medical?
Pediatrix Medical all-time high quarterly cash and cash equivalents is $1.12 B
What is Pediatrix Medical quarterly cash and cash equivalents year-on-year change?
Over the past year, MD quarterly cash and cash equivalents has changed by +$82.65 M (+390.25%)